GE HealthCare Technologies Inc. $GEHC Holdings Lifted by Diamant Asset Management Inc.

Diamant Asset Management Inc. boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7,634.7% during the 1st quarter, Holdings Channel reports. The institutional investor owned 797,216 shares of the company’s stock after buying an additional 786,909 shares during the period. Diamant Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $56,746,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the business. Laurel Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth approximately $27,000. Godfrey Financial Associates Inc. purchased a new position in GE HealthCare Technologies during the fourth quarter valued at approximately $27,000. Montag A & Associates Inc. grew its position in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC increased its stake in GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $65.76 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $29.91 billion, a PE ratio of 15.73, a price-to-earnings-growth ratio of 1.79 and a beta of 0.74. The company has a 50 day moving average price of $64.51 and a two-hundred day moving average price of $73.96. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Peter J. Arduini bought 4,169 shares of the stock in a transaction on Thursday, April 30th. The shares were purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the transaction, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This represents a 1.63% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kevin Lobo bought 10,000 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were bought at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the acquisition, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 21,847 shares of company stock valued at $1,361,355 in the last three months. 0.36% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on GEHC shares. Rothschild & Co Redburn cut their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. BTIG Research lowered their price target on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. JPMorgan Chase & Co. dropped their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Finally, The Goldman Sachs Group reissued a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Ten research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $80.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.